Search results
Subscribe- Long Term Emcure Pharmaceuticals Ltd; Anand Rathi
CNBC Awaaz· 3 days agoAnand Rathi, has come out with its report on Emcure Pharmaceuticals Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.
MC Exclusive: Bansal Wire’s IPO anchor book includes HDFC Mutual Fund, SBI MF, East Spring...
CNBC Awaaz· 3 days agoThe Rs 745-crore IPO, comprising fresh issue of shares, will open for subscription on July 3.
How the B2B Market: Crafting a Customer-Centric Impactful Social Media Strategy
Tribune India· 3 days agoHave you ever wondered why some B2B companies thrive on social media while others struggle to gain traction? In the competitive world of B2B marketing, having a customer-centric and impactful ...
Sensex, Nifty post record closing highs as bank, metal stocks shine; VIX falls 3%
CNBC Awaaz· 2 days agoBenchmark indices Nifty and Sensex had closed the trading session at record highs after a sharp...
Trade setup for Friday: Top 15 things to know before the opening bell
CNBC Awaaz· 23 hours agoExperts expect the Nifty 50 to consolidate with immediate support at 24,200, followed by crucial...
HFT Scan: Ceat and India Cements in focus
CNBC Awaaz· 5 days agoCeat and India Cements closed higher on June 28.
Bot voyage: Can GenAI-based innovation ease turbulence in air travel - The Economic Times
The Economic Times· 3 days agoCustomer satisfaction in India’s fast-growing civil aviation sector has sunk to an all-time low even...
Petro Carbon and Chemicals makes bumper debut, lists with 75% premium on NSE SME
CNBC Awaaz· 3 days agoThe profit per lot for the Petro Carbon and Chemicals debut is Rs 1,03,200
Buy Star Health and Allied Insurance; target of Rs 728: ICICI Securities
CNBC Awaaz· 3 days agoICICI Securities is bullish on Star Health and Allied Insurance has recommended buy rating on the...
Jefferies bullish on ICICI Lombard's 'Elevate' product, stock nears 52-week high
CNBC Awaaz· 3 days agoJefferies highlighted that the unlimited sum insured and customisation options in 'Elevate' could...